[HTML][HTML] A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose …
Background Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease with
poor prognosis and a significant unmet medical need. This study evaluated the safety …
poor prognosis and a significant unmet medical need. This study evaluated the safety …
[PDF][PDF] A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose …
TM Maher, JK Simpson, JC Porter, FJ Wilson, R Chan… - 2020 - scholar.archive.org
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease with
poor prognosis and a significant unmet medical need. This study evaluated the safety …
poor prognosis and a significant unmet medical need. This study evaluated the safety …
[HTML][HTML] A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose …
TM Maher, JK Simpson… - Respiratory …, 2020 - respiratory-research.biomedcentral …
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease with poor
prognosis and a significant unmet medical need. This study evaluated the safety …
prognosis and a significant unmet medical need. This study evaluated the safety …
[PDF][PDF] A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose …
TM Maher, JK Simpson, JC Porter, FJ Wilson, R Chan… - 2020 - core.ac.uk
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease with
poor prognosis and a significant unmet medical need. This study evaluated the safety …
poor prognosis and a significant unmet medical need. This study evaluated the safety …
A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a …
TM Maher, JK Simpson, JC Porter, FJ Wilson… - Respiratory …, 2020 - europepmc.org
Background Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease with
poor prognosis and a significant unmet medical need. This study evaluated the safety …
poor prognosis and a significant unmet medical need. This study evaluated the safety …
A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a …
TM Maher, JK Simpson, JC Porter… - Respiratory …, 2020 - search.ebscohost.com
Abstract < bold> Background: </bold> Idiopathic pulmonary fibrosis (IPF) is a
chronic, progressive lung disease with poor prognosis and a significant unmet medical …
chronic, progressive lung disease with poor prognosis and a significant unmet medical …
A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a …
TM Maher, JK Simpson, JC Porter… - Respiratory …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease with
poor prognosis and a significant unmet medical need. This study evaluated the safety …
poor prognosis and a significant unmet medical need. This study evaluated the safety …
A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a …
TM Maher, JK Simpson, JC Porter… - Respiratory …, 2020 - hull-repository.worktribe.com
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease with
poor prognosis and a significant unmet medical need. This study evaluated the safety …
poor prognosis and a significant unmet medical need. This study evaluated the safety …
A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a …
TM Maher, JK Simpson, JC Porter… - Respiratory …, 2020 - search.proquest.com
Background Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease with
poor prognosis and a significant unmet medical need. This study evaluated the safety …
poor prognosis and a significant unmet medical need. This study evaluated the safety …
A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a …
TM Maher, JK Simpson, JC Porter, FJ Wilson… - Respiratory …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease with poor …
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease with poor …